LivaNova Q2 revenue up 10.8% to $390.6M; raises FY2026 guidance

LivaNova PLC

Q2 GAAP diluted EPS $1.93; adjusted diluted EPS $1.26; revenue $390.6M (+10.8% reported, +9.8% constant currency).
Raised FY2026 constant-currency revenue growth guidance to 8%-9% (up 100 bps); adjusted EPS guidance raised to $4.30-$4.40 (midpoint +$0.10).
Lowered FY2026 adjusted free cash flow guidance to $140M-$160M; Q2 adjusted free cash flow $45.5M.
Recognized €81.8M ($95.4M) discrete tax benefit from favorable Italian tax authority ruling on SNIA environmental liability.
Entered long-term agreement with Thermo Fisher Scientific to increase oxygenator component supply and expand manufacturing output.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.